Package 69097-686-37

{"route": ["TOPICAL"], "spl_id": "01ca8568-cd52-42e0-87b8-2eea35a77364", "openfda": {"nui": ["N0000191279", "N0000000150", "M0002832"], "upc": ["0369097686345", "0369097686376"], "unii": ["K124A4EUQ3"], "rxcui": ["1543177"], "spl_set_id": ["37004451-0345-4e00-96be-f05db600fb9f"], "pharm_class_cs": ["Boron Compounds [CS]"], "pharm_class_epc": ["Oxaborole Antifungal [EPC]"], "pharm_class_moa": ["Protein Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, WITH APPLICATOR in 1 CARTON (69097-686-37)  / 10 mL in 1 BOTTLE, WITH APPLICATOR", "package_ndc": "69097-686-37", "marketing_start_date": "20210218"}], "brand_name": "TAVABOROLE", "product_id": "69097-686_01ca8568-cd52-42e0-87b8-2eea35a77364", "dosage_form": "SOLUTION", "pharm_class": ["Boron Compounds [CS]", "Oxaborole Antifungal [EPC]", "Protein Synthesis Inhibitors [MoA]"], "product_ndc": "69097-686", "generic_name": "TAVABOROLE", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAVABOROLE", "active_ingredients": [{"name": "TAVABOROLE", "strength": "43.5 mg/mL"}], "application_number": "ANDA212224", "marketing_category": "ANDA", "marketing_start_date": "20210218", "listing_expiration_date": "20261231"}